Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,773.50
Bid: 1,772.00
Ask: 1,772.50
Change: 12.50 (0.71%)
Spread: 0.50 (0.028%)
Open: 1,770.00
High: 1,776.00
Low: 1,766.00
Prev. Close: 1,761.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: UK Stocks To Open Higher Ahead Of BoE Minutes

Wed, 22nd Oct 2014 06:35

LONDON (Alliance News) - UK stocks are set to open higher Wednesday, following gains made in the US and Asia and ahead of the release of the minutes from the October meeting of the Monetary Policy Committee of the Bank of England.

Futures indicate the FTSE 100 will open 20 points higher at 6,392.

The UK's leading index, along with other major European indices, made significant gains on Tuesday amid reports that the European Central Bank is looking to take further steps to boost the slowing eurozone economy. Reuters reported that the ECB is considering buying bonds in the secondary market as part of its effort to boost lending in the single currency block. The central bank could take a decision as soon as December, Reuters said.

"The fact that story pushed equities up should be further evidence that it is central banks, not fundamentals, driving market momentum at the moment," says Rabobank analyst Michael Every.

Equity markets have seen a significant increase in volatility recently as investors show their nervousness over whether the global economy is strong enough to stand on its own two feet, without the extra support of the US quantitative easing programme that ends this month.

Hope of further stimulus was enough to help US investors look past mixed earnings and push Wall Street higher. The DJIA gained 1.3% higher, the S&P 500 2.0%, and the Nasdaq Composite 2.4%.

US Technology bellwether Yahoo Inc beat estimates on Tuesday by reporting third quarter earnings per share of USD0.52, much better than the USD0.30 that had been forecast by analysts. The profit includes a 6.3-billion-dollar gain from Yahoo's sale of a stake in the Alibaba Group, as part of the Chinese company's initial public offering in September.

Not all US earnings were so positive however, with McDonald's Corp, for example, reporting earnings per share of USD1.09 in the third quarter, down from USD1.52 last year and missing expectations for USD1.37.

It has been a positive Asian session so far Wednesday, with the Nikkei closing up about 2.5%, while the Hang Seng continues up 1.4%, and the Shanghai Composite is fractionally higher.

The domestic economic focus in the UK Wednesday is the release of the minutes from the latest MPC meeting at the Bank of England. The committee elected to keep the UK base rate on hold at a record low of 0.5% at the meeting earlier this month, but given that two of its members voted for a rate rise in September, investors will be keen to see how the vote was split this month. Given the recent market volatility, calls for rate rises have been somewhat subdued and the consensus expectation is for an unchanged 7-2 vote to keep rates on hold.

One of BoE's most notable hawks, Martin Weale, will be speaking after the market close at 2000 BST in Cambridge. Weale and Ian McCafferty were the two Monetary Policy Committee members to vote for a rate rise last month.

From the UK corporate calendar Wednesday, British American Tobacco has joined the list of names highlighting the impact of the strength of the pound on its earnings. The cigarette maker said its nine-month revenue was up 2.4% at constant exchange rates but down 9.6% at actual rates.

Updates are also out Wednesday from Playtech, International Personal Finance, and Spirit Pub Co. GlaxoSmithKline is reporting third-quarter earnings at 1200 BST.

In the afternoon, the attention will shift to the US where third quarter earnings season continues with a multitude of names including AT&T Inc and Boeing Company reporting.

US consumer price inflation at 1330 BST will be of key interest given the heightened concerns over the strength of the economy as stimulus is withdrawn. The expectation is for a slight fall in CPI to 1.6% year-on-year in September, from 1.7% in August. The US, like the UK, targets 2.0% inflation, and anything greater than the expected 0.1% fall will likely cause some concern, analysts say.

By Jon Darby; jondarby@alliancenews.com; @jondarby100

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.